Safety of hyperbaric oxygen therapy for management of central airway stenosis after lung transplant

What Researchers Did

Researchers investigated the safety of hyperbaric oxygen therapy (HBOT) and its effect on central airway stenosis (CAS) in lung transplant patients with extensive necrotic airway plaques.

What They Found

Hyperbaric oxygen therapy (HBOT) was well tolerated by ten lung transplant patients. While the incidence of central airway stenosis was similar between HBOT-treated and reference patients (70% vs 87%, P=.34), significantly fewer HBOT patients required airway stents (10% vs 56%, P=.03).

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

This was a pilot study with a small sample size, limiting the generalizability of the findings.